Reletter
Artwork for The AI Biopharma Brief

The AI Biopharma Brief

A. I. Milstein

Your weekly digest of recent AI & ML developments in biopharma

Platform
Substack
PricingOnly free issuesPublishesWeekly
Issues10Foundeda year agoLast Issue10 months ago
Active

Read this Newsletter

aimilstein.substack.com
Artwork for The AI Biopharma Brief

Latest Issues

The AI in Biopharma Brief # 9: June 29 2025

Subject: AI in Biopharma: This Week’s Breakthroughs & Insights

From Accelerating Drug Development to Predicting Treatment Outcomes


Stories

Industry News

BIO2025 Recap FDA Reducing Animal Testing Governor Shapiro On Su...

10 months ago

The AI in Biopharma Brief # 8: June 22 2025


From Streamlining FDA Dynamics to Unveiling Hidden Genetic Mutations


All stories

Industry News

Is AI changing FDA-biopharma dynamics?

Breakthrough Tool Enhances Detection of Hidden Genetic Mutations

Thanks fo...

a year ago

The AI in Biopharma Brief # 7: June 15 2025

From Predicting Cancer Immunotherapy Outcomes to Enhancing FDA Guidance Search


All stories

Industry News

Recursion to lay off 20% of staff, a month after slashing its pipeline

Is AI changing FDA-biopharma dynamics? -...

a year ago

The AI in Biopharma Brief # 6: June 8 2025

From FDA’s Elsa Tool to Predicting Drug Binding Affinity and Personalizing Cancer Treatments


All stories

Industry News

FDA’s AI tool ‘Elsa’ is here, and the industry has questions

Thanks for reading The AI Biopharma B...

a year ago

The AI in Biopharma Brief # 5: June 1, 2025


From Streamlining R&D and Production to Uncovering New Therapeutic Targets and Biomarkers


All stories

Industry News

The transformative impact of integrated informatics platforms on biopharma R&D

Thanks for read...

a year ago

Key Facts

Contact Information
Newsletter Author
Number of Subscribers
Find out how many people subscribe to this newsletter.

Audience Metrics

Subscribers, engagement, traffic and sponsorship for The AI Biopharma Brief.

SubscribersMonthly Web VisitsAccepts Sponsors
Estimated Cost per Ad

Authors

The writers behind this newsletter.

  • A. I. Milstein
  • Frequently Asked Questions

    How can I access the email archive for The AI Biopharma Brief?

    You can find recent issues that have been published by The AI Biopharma Brief on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.

    How many subscribers does The AI Biopharma Brief have?

    To see how many people subscribe to The AI Biopharma Brief, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.

    How can I advertise in The AI Biopharma Brief?

    Newsletter advertising can be extremely effective when it's done right. Before you pitch The AI Biopharma Brief as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.

    Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.

    How much does it cost to sponsor a publication like The AI Biopharma Brief?

    Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.

    To find out how much an ad will cost, contact The AI Biopharma Brief using the contact information provided and ask for a copy of their media kit.

    How can I find newsletters related to The AI Biopharma Brief?

    Scroll up to where it says Related Newsletters to see other publications like The AI Biopharma Brief. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.

    How do I contact The AI Biopharma Brief?

    Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.